Fredun Pharmaceuticals: Revised Outcome of Board Meeting Dated 0 3rd October, 2026 Re: Allotment of 1,82,400 Equity Shares to Non -…
Fredun Pharmaceuticals (FREDUN) filed a disclosure titled "Revised Outcome of Board Meeting Dated 0 3rd October, 2026 Re: Allotment of 1,82,400 Equity Shares to Non - Promoter Allottees". The company is valued at about ₹2,254 crore.
What happened
Fredun Pharmaceuticals (FREDUN) filed a disclosure with the exchanges on 5 October 2026 at 08:31 PM titled "Revised Outcome of Board Meeting Dated 0 3rd October, 2026 Re: Allotment of 1,82,400 Equity Shares to Non - Promoter Allottees".
Company snapshot
Fredun Pharmaceuticals is a small-cap company, with a market value of about ₹2,254 crore.
The stock last traded at ₹1,363.2, against a 52-week range of ₹1,195.2–₹1,590 (14.3% below the high).
Before this filing the shares had moved −9.5% over the month. Average daily turnover over the last 20 sessions was about ₹9.66 crore.
Promoters held 44.57% at the end of Q2 FY27. Foreign institutions owned 1.06% and domestic institutions 2.94%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 119 | 6.8 | 14.33 |
| Q2 FY26 | 144 | 9.7 | 20.61 |
| Q3 FY26 | 160 | 10.5 | 19.53 |
| Q4 FY26 | 210 | 11.1 | 20.22 |
| Q1 FY27 | 228 | 13.2 | 23.89 |
What history shows
This is not the company's first corporate update disclosure: BCEIE has 11 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 3.3% on average the next trading day and was down 1.4% on average after five days (7 filings with price data).
Market-wide, 64 corporate update filings with an impact score of 50 or more saw an average next-day move of −1.8%, with 27% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 22 Sept 2026 | Press Release by FPL dated- 22-09-2026 | +3.4% | +3.3% |
| 16 Sept 2026 | Allotment of 2,71,200 Equity Shares to Non-Promoter upon conversion… | +6.7% | +11.4% |
| 15 Sept 2026 | Press Release | −13.5% | −2.1% |
| 15 Sept 2026 | PRESS RELEASE | −13.5% | −2.1% |
| 8 Sept 2026 | Press Release issued by Fredun Pharmaceuticals Limited | +2.4% | −13.1% |
In the news
Recent coverage elsewhere (links open the original publisher):
- Fredun Pharmaceuticals acquires 26% stake in Rs. 300 crore valued Goodman Vetcare
- Fredun Pharmaceuticals Acquires 26% Stake in Goodman Vetcare
- Fredun buys 26% of Goodman Vetcare, valuing pet-care chain at ₹300 crore
- Fredun Pharmaceuticals acquires 26 per cent stake in Goodman Vetcare
- Fredun Pharma acquires 26% stake in Goodman Vetcare Private Limited
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.